Catalyst Capital Advisors’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Catalyst Capital Advisors’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-35,000	Closed	-$220K	–	343
2013 Q2	$220K	Buy	+35,000	New	+$210K	0.17%	176

Other funds holding PBTH

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Catalyst Capital Advisors's PBTH Position: Q3 2013 in Review

Catalyst Capital Advisors sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 35,000 shares — an estimated $220K sold.

Catalyst Capital Advisors first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $220K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Catalyst Capital Advisors reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Catalyst Capital Advisors sold 35,000 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $220K.
Catalyst Capital Advisors first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Catalyst Capital Advisors's PROLOR Biotech, Inc. Common Stock position peaked at $220K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Catalyst Capital Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.